NCT06825624 ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer Status RECRUITING Phase PHASE1
NCT06824467 A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) Status RECRUITING Phase PHASE3
NCT06820463 A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06819007 Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) Status RECRUITING Phase PHASE3
NCT06796907 A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06792695 A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06789757 The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC) Status RECRUITING Phase PHASE2
NCT06788171 PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM Status NOT_YET_RECRUITING Phase PHASE2
NCT06787612 Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer Status RECRUITING Phase PHASE2
NCT06786026 QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC Status RECRUITING Phase PHASE2
NCT06784947 Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06782685 Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV Status RECRUITING Phase PHASE1/PHASE2
NCT06775275 A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC Status RECRUITING Phase PHASE2
NCT06771622 Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06764680 Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06750094 A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy Status RECRUITING Phase PHASE3
NCT06747728 Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain Status RECRUITING Phase NA
NCT06742424 PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC Status RECRUITING Phase PHASE2
NCT06735326 Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer Status RECRUITING Phase PHASE2
NCT06733038 FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients. Status RECRUITING Phase PHASE3